finanznachrichten.de
GeoVax, Inc.: GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies ... mehr ... 20. August 2024